iLoF

Providing a new platform for precise, patient-centric drug development

iLoF (Intelligent Lab on Fiber) is pioneering a breakthrough Al-powered photonics platform to accelerate the future of personalized drug discovery and development. The company has recently secured over $5 million to expand its digital library of biomarkers. Using a cloud-based collection of optical fingerprints, iLoF provides non-invasive, efficient tracking, screening, and stratification for medication development, which is adapted to individual clinical trial needs.

iLoF logo

WEBSITE
ilof.tech

CO-FOUNDER & CEO
Luis Valente

FROM
United Kingdom
Portugal

SOCIAL